A study by Biton et al. demonstrated that COPD patients with NSCLC exhibited higher levels of PD-1/TIM-3 coexpression in CD8+ T cells, suggesting increased T-cell exhaustion and a potential for greater responsiveness to PD-1 blockade [20]. Here, HAVCR2 is linked to non-small cell lung carcinoma.